z-logo
open-access-imgOpen Access
The Oncology Association of Bosnia and Herzegovina's Recommendations for Fertility Preservation in Oncologic Patients
Author(s) -
Timur Cerić,
Emir Sokolović,
Berisa Hasanbegović,
A. Pašić,
Zdenka Gojković,
Jelena Vladičić Mašić,
Nikolina Đukić,
Inga Marijanović,
Alma Mekić Abazović,
Ibrahim Šišić,
Dijana Koprić,
Mustafa Hammami,
S. Beslija
Publication year - 2022
Publication title -
bosnian journal of basic medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 25
eISSN - 1840-4812
pISSN - 1512-8601
DOI - 10.17305/bjbms.2021.6977
Subject(s) - medicine , oncofertility , fertility preservation , fertility , family medicine , quality of life (healthcare) , malignancy , health care , public health , cancer , gynecology , intensive care medicine , nursing , population , environmental health , economic growth , economics
Malignancy is one of the major public health problems in Bosnia and Herzegovina. Along with breakthroughs in specific oncological therapy, improving the quality of life of cancer patients and management of therapy-induced side effects need to be recognized as a priority in the comprehensive cancer patient care. Fertility loss after cancer treatment is a field requiring special attention due to its various consequences on patients themselves.  Although oncofertility is well-recognized area of oncology, low- to middle-income countries are facing issues with its implementation in everyday practice. Increased awareness about fertility preservation is of high priority for all specialists who participate in the medical care of cancer patients. The absence of a systemic solution and lack of expertise led to the founding of Fertility Preservation Working Group of the Oncology Association of Bosnia and Herzegovina. We have made recommendationsas an expert consensus with the ultimate goal of making the first step towards enhancement of oncofertility implementation in Bosnia and Herzegovina.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here